Retrieved from Fuentes Artiles, R., Staub, K., Aldakak, L., et al
Your weight loss journey Starting weight loss medication can feel daunting, but you're not alone
Participants in the semaglutide group had lower rates of all-cause death (19% reduction), CV death (15%), and non-CV death (23%) than placebo recipients
Analysis of FAERS data from 2003 to 2024 showed significant associations between diabetic retinopathy and semaglutide (PRR, 19.43), dulaglutide (PRR, 9.01), and liraglutide (PRR, 4.4) [95]
Many women notice weight gain, particularly around the abdomen, increased insulin resistance, unfavourable changes in cholesterol levels, and a higher risk of developing type 2 diabetes
Is it not